How Belarusian women are building world-class FemTech
Just the other day, the Bill & Melinda Gates Foundation announced a major initiative: $2.5 billion for women’s health solutions by 2030. This confirms once again that systemic attention to women’s health is now at the heart of both public and tech agendas.
FemTech is no longer a niche. It’s one of the fastest-growing tech segments, valued at $55–60 billion (2024–2025) and projected to reach $100–130 billion by 2030–2034, with annual growth rates of 9–16%.
Investment is rising. In 2024, $2.6 billion was invested in FemTech, and if you include conditions more common in women, the figure reaches $10.7 billion. The fastest-growing area is devices and wearables, which are how most users first encounter the industry.
AI as an industry driver
Artificial intelligence is no longer a “feature” but the core of products. It analyses millions of data points from wearables and lab tests, builds forecasts, accelerates R&D, and makes medicine more personalised.
Examples:
Case: Mira — when AI becomes a “personal doctor”
Mira has created a device for at-home hormone testing that connects to an app and delivers results within minutes. Its AI algorithms not only show LH, E3G and PdG levels but also cross-reference them with cycle history to:
Mira’s main differentiator is transparency: the interface turns complex data into clear guidance, for example:
“Your hormone X level has risen — today your probability of ovulation is high. This is where AI stops being a ‘black box’ and becomes a transparent tool that explains its conclusions and engages users in decision-making,” says Eugenia Makarevich , App Product Manager at Mira.
It’s an example of how FemTech transforms data into a tool for managing your health, not just numbers on a report.
Careers in FemTech
The job market is expanding as fast as the product market. “I’ve seen cardiologists become engineers and lawyers turn into product managers,” says Lena Chernogolova , Lead Talent Partner at Flo Health.
Today, the most in-demand roles include:
A striking fact: Even in an industry about women’s health, only 21% of companies have a woman among the founders, and startups with female founders receive just 10% of venture capital.
McKinsey estimates that closing gender gaps in diagnosis and treatment could add $1 trillion a year to the global economy by 2040. This means the future of FemTech is one we can help shape right now.